Mark U Juul

Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models

J. Karlsson, A. Schlicker, C. H. Nielsen, 2021, Clinical Cancer Research.

Darolutamide potentiates the antitumor efficacy of a PSMA-targeted thorium-227 conjugate (PSMA-TTC) by a dual mode-of-action in prostate cancer models

A. Schlicker, B. Haendler, Christine Ellingsen, 2021 .